Hematology
Volume 24, 2019 - Issue 1
Open access
2,389
Views
3
CrossRef citations to date
0
Altmetric
Articles
Efficacy and tolerability of rituximab and reduced-dose cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy for elderly patient with diffuse large B-cell lymphoma
Kensuke KayamoriDepartment of Hematology, Chiba Aoba Municipal Hospital, Chiba, Japan;Department of Hematology, Chiba University Hospital, Chiba, JapanCorrespondence[email protected]
, Katsuhiro ShonoDepartment of Hematology, Chiba Aoba Municipal Hospital, Chiba, Japan
, Masahiro OnodaDepartment of Hematology, Chiba Aoba Municipal Hospital, Chiba, Japan
& Akira YokotaDepartment of Hematology, Chiba Aoba Municipal Hospital, Chiba, Japan
Pages 52-59
|
Published online: 11 Aug 2018
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.